Advertisement

Suppliers' News

Balchem launches a new choline chloride line

The new PuraChol line is available in multiple forms and carrier options. The company has taken the lead on choline research establishing a scientific advisory board to help direct research toward a better understanding of choline’s role in epigenetic expression in animals.

Balchem2
February 5, 2020

Balchem Corporation has invested more than 50 years in research, manufacturing advances, raw ingredient testing and supplier relationship development to deliver the highest quality, purest choline chloride possible. The company is now launching the new PuraChol line of branded choline products.

Available in multiple forms and carrier options, PuraChol is offered as liquid or dry formulations, non-grain, non-GMO, silica carrier, organic carrier and concentrations ranging from 50% to 75%.

“Though the name PuraChol is new. Customers can continue to expect the same premier quality and high standards they’ve come to know from Balchem,” said Jonathan Griffin, vice president, GM of Balchem Animal Nutrition & Health. “We are building on Balchem’s long and distinguished history of scientific and manufacturing excellence with added transparency in our quality testing processes and enhanced supplier quality agreements; all to deliver a line of choline products with unmatched purity, safety and consistency.”

Balchem’s extensive QC testing program analyzes raw materials and finished goods for a range of contaminants including dioxins, mycotoxins, pathogens and pesticides to ensure product quality and purity. Beginning in February 2020, Balchem will release the results of this testing program to customers on a quarterly basis.  

The PuraChol difference extends beyond product-based characteristics to include intangibles like the consumer-driven areas of social responsibility, industry research support and environmental stewardship. The company has taken the lead on choline research in both the human and animal sectors, establishing a scientific advisory board to help direct research toward a better understanding of choline’s role in infant cognition, age-related cognitive decline and liver health in humans while seeking to better understand the impact of choline on epigenetic expression in animals.